Carregant...
Modulatory effects of bortezomib on host immune cell functions
Bortezomib is an inhibitor of the ubiquitin-proteasome proteolytic pathway responsible for intracellular protein turnover. Cellular proteins controlled by this pathway represent a diverse group of potential therapeutic targets, particularly in cancer cells, which exploit this proteasomal pathway to...
Guardat en:
| Publicat a: | Immunotherapy |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4648628/ https://ncbi.nlm.nih.gov/pubmed/26325610 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/imt.15.66 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|